» Articles » PMID: 28943939

Low Expression of MicroRNA-1908 Predicts a Poor Prognosis for Patients with Ovarian Cancer

Overview
Journal Oncol Lett
Specialty Oncology
Date 2017 Sep 26
PMID 28943939
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRs) serve important roles in cancer genesis and progression. The expression of miR-1908 has been reported in a number of types of cancer; however, the clinical significance of miR-1908 in human ovarian cancer (OC) remains unclear. A total of 491 patients with OC from The Cancer Genome Atlas project cohort were selected and divided into two groups according to the median expression level of miR-1908. Univariate and multivariate analyses, using the Kaplan-Meier method and Cox regression, were performed to identify the characteristics that predict OC prognosis. Bioinformatics tools were used to identify potential targets of miR-1908. It was identified that the low expression of miR-1908 is associated with a poor prognosis for OC (P<0.05). The potential target genes of miR-1908 included podocan-like 1, JunB AP-1 transcription factor subunit, homeobox B8, SET binding factor 1 and sirtuin 2; high expression of these five genes additionally predicted a poor prognosis. These results suggest that miR-1908 may be a suitable target for the development of novel approaches in OC diagnosis and therapy in the future.

Citing Articles

A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer-State-of-the-Art Review and Future Perspectives.

Kolakowska K, Kisluk J, Niklinski J Int J Mol Sci. 2025; 26(5).

PMID: 40076482 PMC: 11900017. DOI: 10.3390/ijms26051857.


Utilization of miRNAs as Biomarkers for the Diagnosis, Prognosis, and Metastasis in Gynecological Malignancies.

Lazaridis A, Katifelis H, Kalampokas E, Lambropoulou D, Aravantinos G, Gazouli M Int J Mol Sci. 2024; 25(21).

PMID: 39519256 PMC: 11546551. DOI: 10.3390/ijms252111703.


JunB: a paradigm for Jun family in immune response and cancer.

Ren F, Cai X, Yao Y, Fang G Front Cell Infect Microbiol. 2023; 13:1222265.

PMID: 37731821 PMC: 10507257. DOI: 10.3389/fcimb.2023.1222265.


Small Leucine-Rich Proteoglycan Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting.

Dai G, Sun Y, Wei R, Xi L Curr Issues Mol Biol. 2023; 45(7):6116-6139.

PMID: 37504302 PMC: 10378008. DOI: 10.3390/cimb45070386.


MiR-942-3p as a Potential Prognostic Marker of Gastric Cancer Associated with AR and MAPK/ERK Signaling Pathway.

Liu W, Ying N, Rao X, Chen X Curr Issues Mol Biol. 2022; 44(9):3835-3848.

PMID: 36135175 PMC: 9498168. DOI: 10.3390/cimb44090263.


References
1.
Corney D, Hwang C, Matoso A, Vogt M, Flesken-Nikitin A, Godwin A . Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res. 2010; 16(4):1119-28. PMC: 2822884. DOI: 10.1158/1078-0432.CCR-09-2642. View

2.
Rawlings-Goss R, Campbell M, Tishkoff S . Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genomics. 2014; 7:53. PMC: 4159108. DOI: 10.1186/1755-8794-7-53. View

3.
Kilic Eren M, Kilincli A, Eren O . Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation. PLoS One. 2015; 10(4):e0124837. PMC: 4414559. DOI: 10.1371/journal.pone.0124837. View

4.
Atsaves V, Lekakis L, Drakos E, Leventaki V, Ghaderi M, Baltatzis G . The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma. Br J Haematol. 2014; 167(4):514-23. DOI: 10.1111/bjh.13079. View

5.
Xie C, Shi K, Zhang X, Zhao J, Yu J . MiR-1908 promotes scar formation post-burn wound healing by suppressing Ski-mediated inflammation and fibroblast proliferation. Cell Tissue Res. 2016; 366(2):371-380. DOI: 10.1007/s00441-016-2434-6. View